Drug Pipeline

Drug Pipeline Market Research Reports

1 . Drug Pipeline Market Research Reports Analysis and Trends

Discovering and bringing new drugs to mainstream commercial market typically takes an average of 10-15 years of research and clinical development efforts. Drug developers need to make sure safe and effective drug available for patient in quick time. The first step is to target the protein available in the patient’s body that is associated with microorganism causing a disease, through tracking of cellular network of proteins an appropriate target for a drug is selected. Through a series of trials, right drug candidate got chosen.
 
According to “NOVARTIS”, bringing a new drug in market takes 14 years of research and cost around USD 2 billion, 10K+ clinical trials out of these, one leads to successful drug development.
Titlesort descending Published Pages Price
5-Hydroxytryptamine Receptor 4 (5 HT4 or Serotonin Receptor 4 or HTR4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 43 USD 2,500.00
5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H1 2018 Mar 13 2018 69 USD 3,500.00
5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H2 2018 Sep 11 2018 63 USD 3,500.00
5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021 Jul 30 2021 63 USD 3,500.00
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H1 2020 Mar 31 2020 61 USD 3,500.00
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H2 2019 Dec 27 2019 62 USD 3,500.00
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H2 2020 Oct 30 2020 62 USD 3,500.00
5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) - Pipeline Review, H1 2018 May 8 2018 66 USD 3,500.00
5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) - Pipeline Review, H2 2018 Nov 13 2018 70 USD 3,500.00
5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 83 USD 3,500.00
5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2021 Jun 30 2021 85 USD 3,500.00
5-Hydroxytryptamine Receptor 7 - Pipeline Review, H1 2020 Mar 31 2020 74 USD 3,500.00
5-Hydroxytryptamine Receptor 7 - Pipeline Review, H2 2019 Dec 27 2019 75 USD 3,500.00
5-Hydroxytryptamine Receptor 7 - Pipeline Review, H2 2020 Sep 30 2020 76 USD 3,500.00
50S Ribosomal Subunit (50S RNA) - Drugs in Development, 2021 Apr 30 2021 30 USD 3,000.00
50S Ribosomal Subunit (50S RNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 37 USD 2,500.00
70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Drugs in Development, 2021 Apr 30 2021 35 USD 3,000.00
70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 37 USD 2,500.00
72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H1 2018 Jan 18 2018 33 USD 3,500.00
72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H1 2019 Mar 26 2019 32 USD 3,500.00
72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018 Jul 17 2018 32 USD 3,500.00
72 kDa Type IV Collagenase - Pipeline Review, H2 2019 Aug 30 2019 32 USD 3,500.00
78 kda Glucose Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+) Binding Protein Grp78 or Heat Shock 70 kDa Protein 5 or Immunoglobulin Heavy Chain Binding Protein or HSPA5) - Drugs in Development, 2021 Apr 30 2021 30 USD 3,000.00
78 kda Glucose Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+) Binding Protein Grp78 or Heat Shock 70 kDa Protein 5 or Immunoglobulin Heavy Chain Binding Protein or HSPA5) - Pipeline Review, H2 2018 Jul 10 2018 42 USD 3,500.00
78 kda Glucose Regulated Protein - Pipeline Review, H2 2019 Dec 27 2019 47 USD 3,500.00
A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) - Pipeline Review, H1 2018 Jun 12 2018 55 USD 3,500.00
A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Pipeline Review, H1 2020 Feb 28 2020 62 USD 3,500.00
A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Pipeline Review, H2 2019 Dec 27 2019 65 USD 3,500.00
Acetyl CoA Carboxylase (Acetyl Coenzyme A Carboxylase or ACC or EC 6.4.1.2) - Drugs in Development, 2021 Apr 30 2021 30 USD 3,000.00
Acetyl CoA Carboxylase (Acetyl Coenzyme A Carboxylase or ACC or EC 6.4.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 43 USD 2,500.00
Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14) - Drugs in Development, 2021 Apr 30 2021 30 USD 3,000.00
Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 36 USD 2,500.00
Acetylcholinesterase (Acetylcholine Hydrolase or Yt Blood Group or Apoptosis Related Acetylcholinesterase or ACHE or EC 3.1.1.7) - Drugs in Development, 2021 Apr 30 2021 105 USD 3,000.00
Acetylcholinesterase (Acetylcholine Hydrolase or Yt Blood Group or Apoptosis Related Acetylcholinesterase or ACHE or EC 3.1.1.7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 86 USD 2,500.00
Achondroplasia (Musculoskeletal) - Drugs In Development, 2021 Jul 30 2021 83 USD 2,000.00
Achondroplasia - Pipeline Review, H1 2018 Mar 13 2018 43 USD 2,000.00
Achondroplasia - Pipeline Review, H1 2020 Mar 31 2020 60 USD 2,000.00
Achondroplasia - Pipeline Review, H2 2018 Sep 11 2018 49 USD 2,000.00
Achondroplasia - Pipeline Review, H2 2019 Nov 25 2019 57 USD 2,000.00
Achondroplasia - Pipeline Review, H2 2020 Sep 30 2020 66 USD 2,000.00
Achondroplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 61 USD 2,000.00
Achromatopsia (Genetic Disorders) - Drugs in Development, 2021 Apr 30 2021 30 USD 2,000.00
Achromatopsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 36 USD 2,000.00
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A (Genetic Disorders) - Drugs in Development, 2021 Apr 30 2021 35 USD 2,000.00
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 37 USD 2,000.00
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Development, 2021 Apr 30 2021 35 USD 2,000.00
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 38 USD 2,000.00
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H1 2018 Apr 30 2018 78 USD 2,000.00
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H1 2020 Apr 30 2020 109 USD 2,000.00
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H2 2018 Oct 16 2018 91 USD 2,000.00

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected